The last two years have been some of the most remarkable years in pharmaceutical history. There were 46 FDA approvals in 2017, and this year we have received a record 59 approvals. Orhan
Caglayan at CPhI Worlwide and bioLIVE explores how we might now be entering a golden age of innovation for pharmaceutical R&D, but what is most encouraging is that this new era of increased productivity is translating into drug delivery devices and packaging as well. Many of the experts believe that this new age of innovation is a golden opportunity for drug delivery and device manufacturers to bring new technologies to patients.
[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/04/The-drug-delivery-innovation-league-table.pdf” width=”100%” height=”900px” style=”border:0;”]